Global Human Microbiome Therapeutics Market Size, Status and Forecast 2019-2025

2019-01-14 / 3900.00 / Pharma & Healthcare / 97 Pages

Description

Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Microbiome therapeutics are therapies that are designed to disrupt unhealthy microbial ecological networks and that catalyse the establishment of healthy ones.
One of the major drivers for this market is side effects of the existing treatments. Various medicines available in the market have several side-effects including minor headaches. These medicines may also impart serious side-effects such as liver or kidney injury, heart problems, and even death. The seriousness of side-effects drives the need for innovative treatment technologies, such as human microbiome therapeutics, that have reduced the negative impact on the human body. The demand for microbiome therapeutics is increasing since it provides treatment sans chemicals.
The latest trend gaining momentum in the market is growing investments from venture capitalists. Venture capitalists are capitalizing on the need for effective treatment and are offering therapeutic treatment solutions to treat disorders such as autoimmune disorders, infections, and cancer. 
In 2018, the global Human Microbiome Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Human Microbiome Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Microbiome Therapeutics development in United States, Europe and China.

The key players covered in this study
Enterome Bioscience
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson & Johnson
Takeda Pharmaceutical
...

Market segment by Type, the product can be split into
FMT
Microbiome Drugs

Market segment by Application, split into
C. difficile
Crohn’s Disease
Inflammatory Bowel Disease
Diabetes
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Human Microbiome Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Human Microbiome Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Human Microbiome Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 FMT
1.4.3 Microbiome Drugs
1.5 Market by Application
1.5.1 Global Human Microbiome Therapeutics Market Share by Application (2014-2025)
1.5.2 C. difficile
1.5.3 Crohn’s Disease
1.5.4 Inflammatory Bowel Disease
1.5.5 Diabetes
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Human Microbiome Therapeutics Market Size
2.2 Human Microbiome Therapeutics Growth Trends by Regions
2.2.1 Human Microbiome Therapeutics Market Size by Regions (2014-2025)
2.2.2 Human Microbiome Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Human Microbiome Therapeutics Market Size by Manufacturers
3.1.1 Global Human Microbiome Therapeutics Revenue by Manufacturers (2014-2018)
3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Manufacturers (2014-2018)
3.1.3 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Human Microbiome Therapeutics Key Players Head office and Area Served
3.3 Key Players Human Microbiome Therapeutics Product/Solution/Service
3.4 Date of Enter into Human Microbiome Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Human Microbiome Therapeutics Market Size by Type (2014-2019)
4.2 Global Human Microbiome Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Human Microbiome Therapeutics Market Size (2014-2019)
5.2 Human Microbiome Therapeutics Key Players in United States
5.3 United States Human Microbiome Therapeutics Market Size by Type
5.4 United States Human Microbiome Therapeutics Market Size by Application

6 Europe
6.1 Europe Human Microbiome Therapeutics Market Size (2014-2019)
6.2 Human Microbiome Therapeutics Key Players in Europe
6.3 Europe Human Microbiome Therapeutics Market Size by Type
6.4 Europe Human Microbiome Therapeutics Market Size by Application

7 China
7.1 China Human Microbiome Therapeutics Market Size (2014-2019)
7.2 Human Microbiome Therapeutics Key Players in China
7.3 China Human Microbiome Therapeutics Market Size by Type
7.4 China Human Microbiome Therapeutics Market Size by Application

8 Japan
8.1 Japan Human Microbiome Therapeutics Market Size (2014-2019)
8.2 Human Microbiome Therapeutics Key Players in Japan
8.3 Japan Human Microbiome Therapeutics Market Size by Type
8.4 Japan Human Microbiome Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Human Microbiome Therapeutics Market Size (2014-2019)
9.2 Human Microbiome Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Human Microbiome Therapeutics Market Size by Type
9.4 Southeast Asia Human Microbiome Therapeutics Market Size by Application

10 India
10.1 India Human Microbiome Therapeutics Market Size (2014-2019)
10.2 Human Microbiome Therapeutics Key Players in India
10.3 India Human Microbiome Therapeutics Market Size by Type
10.4 India Human Microbiome Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Human Microbiome Therapeutics Market Size (2014-2019)
11.2 Human Microbiome Therapeutics Key Players in Central & South America
11.3 Central & South America Human Microbiome Therapeutics Market Size by Type
11.4 Central & South America Human Microbiome Therapeutics Market Size by Application

12 International Players Profiles
12.1 Enterome Bioscience
12.1.1 Enterome Bioscience Company Details
12.1.2 Company Description and Business Overview
12.1.3 Human Microbiome Therapeutics Introduction
12.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2014-2019)
12.1.5 Enterome Bioscience Recent Development
12.2 Rebiotix
12.2.1 Rebiotix Company Details
12.2.2 Company Description and Business Overview
12.2.3 Human Microbiome Therapeutics Introduction
12.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2014-2019)
12.2.5 Rebiotix Recent Development
12.3 Seres Therapeutics
12.3.1 Seres Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Human Microbiome Therapeutics Introduction
12.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2014-2019)
12.3.5 Seres Therapeutics Recent Development
12.4 Vedanta Biosciences
12.4.1 Vedanta Biosciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 Human Microbiome Therapeutics Introduction
12.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2014-2019)
12.4.5 Vedanta Biosciences Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Human Microbiome Therapeutics Introduction
12.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Company Details
12.6.2 Company Description and Business Overview
12.6.3 Human Microbiome Therapeutics Introduction
12.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2014-2019)
12.6.5 Johnson & Johnson Recent Development
12.7 Takeda Pharmaceutical
12.7.1 Takeda Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Human Microbiome Therapeutics Introduction
12.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2014-2019)
12.7.5 Takeda Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details


Table of Figures

List of Tables and Figures

Table Human Microbiome Therapeutics Key Market Segments
Table Key Players Human Microbiome Therapeutics Covered
Table Global Human Microbiome Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Human Microbiome Therapeutics Market Size Market Share by Type 2014-2025
Figure FMT Figures
Table Key Players of FMT
Figure Microbiome Drugs Figures
Table Key Players of Microbiome Drugs
Table Global Human Microbiome Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure C. difficile Case Studies
Figure Crohn’s Disease Case Studies
Figure Inflammatory Bowel Disease Case Studies
Figure Diabetes Case Studies
Figure Others Case Studies
Figure Human Microbiome Therapeutics Report Years Considered
Table Global Human Microbiome Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Human Microbiome Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Human Microbiome Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Human Microbiome Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Human Microbiome Therapeutics Market Share by Regions 2014-2019
Figure Global Human Microbiome Therapeutics Market Share by Regions 2014-2019
Figure Global Human Microbiome Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Human Microbiome Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Human Microbiome Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Human Microbiome Therapeutics Market Share by Manufacturers in 2018
Table Global Human Microbiome Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Human Microbiome Therapeutics Product/Solution/Service
Table Date of Enter into Human Microbiome Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Human Microbiome Therapeutics Market Size Share by Type (2014-2019)
Figure Global Human Microbiome Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Human Microbiome Therapeutics Market Size Share by Application (2014-2019)
Figure Global Human Microbiome Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Human Microbiome Therapeutics Revenue Market Share by Application in 2018
Figure United States Human Microbiome Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Human Microbiome Therapeutics Market Share (2018-2019)
Table United States Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Human Microbiome Therapeutics Market Share by Type (2014-2019)
Table United States Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Human Microbiome Therapeutics Market Share by Application (2014-2019)
Figure Europe Human Microbiome Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Human Microbiome Therapeutics Market Share (2018-2019)
Table Europe Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Human Microbiome Therapeutics Market Share by Type (2014-2019)
Table Europe Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Human Microbiome Therapeutics Market Share by Application (2014-2019)
Figure China Human Microbiome Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Human Microbiome Therapeutics Market Share (2018-2019)
Table China Human Microbiome Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Human Microbiome Therapeutics Market Share by Type (2014-2019)
Table China Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Human Microbiome Therapeutics Market Share by Application (2014-2019)
Figure Japan Human Microbiome Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Human Microbiome Therapeutics Market Share (2018-2019)
Table Japan Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Human Microbiome Therapeutics Market Share by Type (2014-2019)
Table Japan Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Human Microbiome Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Human Microbiome Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Human Microbiome Therapeutics Market Share (2018-2019)
Table Southeast Asia Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Human Microbiome Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Human Microbiome Therapeutics Market Share by Application (2014-2019)
Figure India Human Microbiome Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Human Microbiome Therapeutics Market Share (2018-2019)
Table India Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Human Microbiome Therapeutics Market Share by Type (2014-2019)
Table India Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Human Microbiome Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Human Microbiome Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Human Microbiome Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Human Microbiome Therapeutics Market Share (2018-2019)
Table Central & South America Human Microbiome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Human Microbiome Therapeutics Market Share by Type (2014-2019)
Table Central & South America Human Microbiome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Human Microbiome Therapeutics Market Share by Application (2014-2019)
Table Enterome Bioscience Company Details
Table Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2014-2019) (Million US$)
Figure Enterome Bioscience Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019)
Table Enterome Bioscience Recent Development
Table Rebiotix Company Details
Table Rebiotix Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$)
Figure Rebiotix Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019)
Table Rebiotix Recent Development
Table Seres Therapeutics Company Details
Table Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$)
Figure Seres Therapeutics Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019)
Table Seres Therapeutics Recent Development
Table Vedanta Biosciences Company Details
Table Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$)
Figure Vedanta Biosciences Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019)
Table Vedanta Biosciences Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Human Microbiome Therapeutics Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Global Human Microbiome Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Human Microbiome Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Human Microbiome Therapeutics Market Size Share by Regions in 2025
Figure United States Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Human Microbiome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Human Microbiome Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Human Microbiome Therapeutics Market Size by Product (2019-2025)
Figure Global Human Microbiome Therapeutics Market Size by Product in 2025
Table Global Human Microbiome Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Human Microbiome Therapeutics Market Size by Application (2019-2025)
Figure Global Human Microbiome Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory